ArticleScientific reports2024

Monitoring anti-factor Xa activity in patients with chronic thromboembolic pulmonary hypertension treated with factor Xa inhibitors.

Yoshihisa Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.